J Hafner

Summary

Affiliation: University of Zurich
Country: Switzerland

Publications

  1. ncbi Micrographic surgery ('slow Mohs') in cutaneous sarcomas
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Dermatology 198:37-43. 1999
  2. ncbi Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers
    J Hafner
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Arch Dermatol 137:599-603. 2001
  3. ncbi [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]
    J Hafner
    Dermatologische Klinik und Poliklinik, Universitatsspital Zurich
    Praxis (Bern 1994) 88:1170-7. 1999
  4. ncbi Axillary sweat gland excision
    Jürg Hafner
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Curr Probl Dermatol 30:57-63. 2002
  5. ncbi Instruction of compression therapy by means of interface pressure measurement
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Dermatol Surg 26:481-6; discussion 487. 2000
  6. ncbi A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH8091 Zurich, Switzerland
    Arch Dermatol 136:857-63. 2000
  7. ncbi [Conservative therapy in varicose symptom complex]
    J Hafner
    Dermatologische Klinik und Poliklinik, Universitatsspital Zurich
    Praxis (Bern 1994) 90:197-204. 2001
  8. ncbi Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms
    G F Hofbauer
    Department of Dermatology, Department of Internal Medicine, University Hospital, Zurich, Switzerland
    Dermatology 202:359-61. 2001
  9. ncbi A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients
    G Dragieva
    Department of Dermatology, University Hospital of Zurich, 31 Gloriastr, 8091 Zurich, Switzerland
    Br J Dermatol 151:196-200. 2004
  10. ncbi Proteus syndrome
    G Dragieva
    Department of Dermatology, University Hospital of Zurich
    Vasa 32:159-63. 2003

Collaborators

Detail Information

Publications20

  1. ncbi Micrographic surgery ('slow Mohs') in cutaneous sarcomas
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Dermatology 198:37-43. 1999
    ..Micrographic surgery (MS) results in very low local recurrence rates in all sorts of skin tumours that grow by extensive subclinical infiltration. Therefore, MS should prove useful in the treatment of cutaneous sarcomas...
  2. ncbi Factor V Leiden mutation in postthrombotic and non-postthrombotic venous ulcers
    J Hafner
    Department of Dermatology, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Arch Dermatol 137:599-603. 2001
    ..To determine the prevalence of the factor V Leiden mutation in patients with postthrombotic and non-postthrombotic venous ulcers...
  3. ncbi [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]
    J Hafner
    Dermatologische Klinik und Poliklinik, Universitatsspital Zurich
    Praxis (Bern 1994) 88:1170-7. 1999
    ..In summary, optimization of prevention and treatment of the diabetic foot syndrome should allow for substantial reduction of amputations...
  4. ncbi Axillary sweat gland excision
    Jürg Hafner
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Curr Probl Dermatol 30:57-63. 2002
  5. ncbi Instruction of compression therapy by means of interface pressure measurement
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Dermatol Surg 26:481-6; discussion 487. 2000
    ..Compression therapy of the leg is the cornerstone in the conservative treatment of venous ulcers. The application of compression bandages, however, is largely a matter of personal experience...
  6. ncbi A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH8091 Zurich, Switzerland
    Arch Dermatol 136:857-63. 2000
    ..To study the interface pressure between the leg and 8 different multilayer bandage systems during postural changes, exercise (walking), and over 2 days of wear time...
  7. ncbi [Conservative therapy in varicose symptom complex]
    J Hafner
    Dermatologische Klinik und Poliklinik, Universitatsspital Zurich
    Praxis (Bern 1994) 90:197-204. 2001
    ..Moreover, the role and differential indication of synthetic dressings in the local therapy of chronic leg ulcers is explained in-depth...
  8. ncbi Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms
    G F Hofbauer
    Department of Dermatology, Department of Internal Medicine, University Hospital, Zurich, Switzerland
    Dermatology 202:359-61. 2001
    ..The diagnostic approach, differential diagnosis and treatment options are discussed emphasizing the characteristics of cutaneous lesions in immunosuppressed transplant recipients...
  9. ncbi A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients
    G Dragieva
    Department of Dermatology, University Hospital of Zurich, 31 Gloriastr, 8091 Zurich, Switzerland
    Br J Dermatol 151:196-200. 2004
    ..Transplant recipients have an increased propensity to develop multiple actinic keratoses, which demonstrate an increased transformation rate into invasive squamous cell carcinoma...
  10. ncbi Proteus syndrome
    G Dragieva
    Department of Dermatology, University Hospital of Zurich
    Vasa 32:159-63. 2003
    ..The possible aetiology, clinical manifestations, differential diagnosis and management of this rare disorder are discussed...
  11. ncbi Baseline staging in cutaneous malignant melanoma
    J Hafner
    Department of Dermatology, Institute of Social and Preventive Medicine, University Hospital of Zurich, CH 8091 Zurich, Switzerland
    Br J Dermatol 150:677-86. 2004
    ..Baseline staging in patients with primary cutaneous malignant melanoma (MM) is routine, but the diagnostic accuracy and the impact on clinical outcome are still unclear...
  12. doi Mammalian target of rapamycin (mTOR) inhibitors slow skin carcinogenesis, but impair wound healing
    L Feldmeyer
    Department of Dermatology, University Hospital Zurich, Gloriastrasse 31, 8091 Zurich, Switzerland
    Br J Dermatol 166:422-4. 2012
    ..While randomized trials are running, organ transplant recipients are frequently switched from calcineurin inhibitors to mTOR inhibitors when cutaneous carcinogenesis increases...
  13. ncbi The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification
    M Beyeler
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Onkologie 27:401-6. 2004
    ..Early detection and removal is critical since mesenchymal skin tumors often cannot be cured by radiation or chemotherapy...
  14. ncbi Imiquimod in basal cell carcinoma: how does it work?
    R Dummer
    Department of Dermatology, University Hospital of Zurich, Gloriastrasse 31, CH 8091 Zurich, Switzerland
    Br J Dermatol 149:57-8. 2003
    ..Our findings demonstrate that imiquimod-induced BCC regression is associated with a strong activity of the innate immune response, mediated by cells of macrophage-monocyte origin and is associated with the induction of apoptosis...
  15. ncbi Post-surgical scalp wounds with exposed bone treated with a plant-derived wound therapeutic
    S Lauchli
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    J Wound Care 21:228, 230, 232-3. 2012
    ..To evaluate the efficacy of a plant-derived wound dressing, a mixture of hypericum oil (Hypericum perforatum) and neem oil (Azadirachta indica), in scalp wounds with exposed bone...
  16. doi Evidence that venous hypertension causes stasis dermatitis
    K Sippel
    Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
    Phlebology 26:361-5. 2011
    ..Lower leg dermatitis healed in all 10 patients within 8-12 weeks and no recurrence was observed (1 year follow-up). These results support clinical experience that venous hypertension alone indeed can cause lower leg dermatitis...
  17. ncbi Malignant fibrous histiocytoma and atypical fibroxanthoma in renal transplant recipients
    J Hafner
    Department of Dermatology, University Hospital of Zurich, Switzerland
    Dermatology 198:29-32. 1999
    ..The incidence of Kaposi's sarcoma is increased 400 to 500 times over that in a control population of the same ethnic origin. However, the incidence of other types of cutaneous sarcoma in organ allograft recipients is largely unknown...
  18. doi Non-invasive pressure measurement of the great saphenous vein in healthy controls and patients with venous insufficiency
    M Koster
    Clinic for Angiology, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland
    Clin Hemorheol Microcirc 54:325-32. 2013
    ....
  19. ncbi Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related?
    U Bader
    Department of Dermatology, University Hospital, Zurich, Switzerland
    Dermatology 200:45-8. 2000
    ..We conclude that differentiation between disease-related and treatment-induced leg ulcers can be difficult and may not always be possible. In HU-induced leg ulcers, cessation of the drug typically leads to wound healing...
  20. ncbi Treatment of verrucous carcinoma with imiquimod and CO2 laser ablation
    L M Heinzerling
    University Hospital Zurich, Zurich, Switzerland
    Dermatology 207:119-22. 2003
    ..In a third session, tumor parts in the anal canal were vaporized. This case demonstrates that the combination of imiquimod and CO2 laser ablation is an effective treatment option for verrucous carcinoma...